Ocular autoimmune disease involves the immune system attacking the tissues of the eye. These diseases typically manifest through an autoantibody response targeting the retina, uvea, vitreous, and orbital tissues. Common ocular autoimmune diseases include thyroid eye disease, orbital inflammatory pseudotumor, uveitis, IgG4-related eye disease, Sjögren’s syndrome, and optic neuritis, among others. These conditions frequently cause inflammation and tissue damage, leading to symptoms such as eye discomfort, blurred vision, impaired visual function, altered appearance, and even blindness. Consequently, there is an urgent need for advanced understanding of their pathogenesis, prevention, diagnosis, and treatment.
This Research Topic aims to explore advancements in the immunological mechanisms underlying these diseases, as well as novel insights into diagnostic and therapeutic approaches.
We welcome submissions of original research, reviews, case reports, and clinical trials for this topic. To further enhance our understanding and treatment of these complex diseases, we encourage submissions across a broad spectrum of related themes, particularly:
• New insights into the immunological mechanisms driving autoimmune diseases that affect ocular health;
• Innovations in early prediction, detection, and diagnosis of autoimmune-related ocular diseases, including imaging modalities and laboratory science;
• Advances in therapeutic approaches for autoimmune-related ocular diseases;
• The role of diet and gut microbiota in autoimmune-related ocular diseases;
• Mental state and quality of life in patients with chronic autoimmune-related ocular diseases;
• Detailed clinical insights and case studies in ocular autoimmune management.
Keywords:
Autoimmune Diseases, Ocular Disease, Immunological Mechanisms, Diagnosis, Therapy
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Ocular autoimmune disease involves the immune system attacking the tissues of the eye. These diseases typically manifest through an autoantibody response targeting the retina, uvea, vitreous, and orbital tissues. Common ocular autoimmune diseases include thyroid eye disease, orbital inflammatory pseudotumor, uveitis, IgG4-related eye disease, Sjögren’s syndrome, and optic neuritis, among others. These conditions frequently cause inflammation and tissue damage, leading to symptoms such as eye discomfort, blurred vision, impaired visual function, altered appearance, and even blindness. Consequently, there is an urgent need for advanced understanding of their pathogenesis, prevention, diagnosis, and treatment.
This Research Topic aims to explore advancements in the immunological mechanisms underlying these diseases, as well as novel insights into diagnostic and therapeutic approaches.
We welcome submissions of original research, reviews, case reports, and clinical trials for this topic. To further enhance our understanding and treatment of these complex diseases, we encourage submissions across a broad spectrum of related themes, particularly:
• New insights into the immunological mechanisms driving autoimmune diseases that affect ocular health;
• Innovations in early prediction, detection, and diagnosis of autoimmune-related ocular diseases, including imaging modalities and laboratory science;
• Advances in therapeutic approaches for autoimmune-related ocular diseases;
• The role of diet and gut microbiota in autoimmune-related ocular diseases;
• Mental state and quality of life in patients with chronic autoimmune-related ocular diseases;
• Detailed clinical insights and case studies in ocular autoimmune management.
Keywords:
Autoimmune Diseases, Ocular Disease, Immunological Mechanisms, Diagnosis, Therapy
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.